Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000-2008).
about
Evaluating beneficial drug effects in a non-interventional setting: a review of effectiveness studies based on Swedish Prescribed Drug Register data.Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy.Clinicopathological and prognostic factors for long-term survival in Chinese patients with metastatic renal cell carcinoma treated with sorafenib: a single-center retrospective studyTreatment, Outcome and Prognostic Factors in Renal Cell Carcinoma - A Single Center Study (2000-2010).Long-term survival correlates with immunological responses in renal cell carcinoma patients treated with mRNA-based immunotherapy.Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma.Overall survival in renal cell carcinoma after introduction of targeted therapies: a Norwegian population-based study.Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma.Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma.First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.Prognostic factors in patients with advanced renal cell carcinoma treated with VEGF-targeted agents.A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma.Prognostic factors and risk classifications for patients with metastatic renal cell carcinoma.First-line treatment in the management of advanced renal cell carcinoma: systematic review and network meta-analysis.Current status of clinical trials assessing oncolytic virus therapy for urological cancers.Long-term response to sunitinib: everolimus treatment in metastatic clear cell renal cell carcinoma.Arsenic trioxide amplifies cisplatin toxicity in human tubular cells transformed by HPV-16 E6/E7 for further therapeutic directions in renal cell carcinoma.XRCC1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis through suppressing MMP-2 and MMP-9.Adjuvant therapy in renal cell carcinoma: does higher risk for recurrence improve the chance for success?Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.Prognostic significance of serum albumin in patients with metastatic renal cell carcinoma.Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer.The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria.Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the National Swedish Kidney Cancer Register
P2860
Q31147482-4AAED00C-9929-4BEE-8CE8-02825E9BFA70Q35674216-937F46D7-6D1E-42AC-B234-69193AA16046Q36546814-1928644B-FB06-4929-A0A8-A515A7CB7CC3Q37012044-8C80FA51-CCDF-4269-B06F-733860ABD73CQ37012691-D41E416B-DDA7-436E-904A-35FBED08589CQ37433431-93D21B32-544F-4330-8451-0417B6F9294CQ37596123-E01E5E98-C4F8-4953-8433-16D5BFFF285FQ37616807-93E4FC16-954A-4DBF-AE7B-DFA6E1D887C1Q37672483-F0DCB581-7D1D-4F65-81BA-5A25E4D01D4AQ37711680-17240B8A-A9DE-432A-87A9-5BC1873572EFQ38196855-65CD50DB-C3B7-458D-8DB0-5E18D8D20AF5Q38373731-39A82DC0-8B47-447A-9AEB-3321571B6AB0Q38543085-5A54F297-5EF5-4BBF-8A5C-C8BC86DA8B66Q38550942-719DD65B-7336-41E4-B844-B53062C6128AQ38741837-9649F4D3-BE18-45A6-818E-B96FBB2E7945Q38823987-71E24D46-B1B7-409E-ACCC-C518894E0A1FQ41637438-DD2268D7-EC3F-43F3-B9AB-16503F8BD2E7Q47193685-192EE873-7EBB-41BB-B647-44BA27157F12Q47397616-BCB598DE-389E-46DC-B852-94BD22531610Q48556269-0A983486-F98A-4AFB-95B1-FD3624ABE4B8Q50727767-2143381A-68B8-4CE9-9B9C-191DD3D4257BQ55240294-38C45ED1-A117-4BEB-A95F-B1A2DEA5606DQ55378351-5A35789E-72DA-4BCE-9B1D-1200B21A6859Q59264995-0190118F-67AF-4745-B75A-93E27858B1A7
P2860
Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000-2008).
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Treatment and overall survival ...... ation-based study (2000-2008).
@ast
Treatment and overall survival ...... ation-based study (2000-2008).
@en
type
label
Treatment and overall survival ...... ation-based study (2000-2008).
@ast
Treatment and overall survival ...... ation-based study (2000-2008).
@en
prefLabel
Treatment and overall survival ...... ation-based study (2000-2008).
@ast
Treatment and overall survival ...... ation-based study (2000-2008).
@en
P2093
P2860
P356
P1476
Treatment and overall survival ...... ation-based study (2000-2008).
@en
P2093
J Kowalski
M Jakobsson
P Sandström
S Lundstam
T Wahlgren
U Harmenberg
P2860
P2888
P304
P356
10.1038/BJC.2013.119
P407
P577
2013-03-26T00:00:00Z